Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Block

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Aging|November 20, 2015
Reversing cancer stemnessJames Block, Fanyan Meng, Guojun Wu
Scientific Reports|November 30, 2019
A stroma-corrected ZEB1 transcriptional signature is inversely associated with antitumor immune activity in breast cancerC James Block, Gregory Dyson, Ion John Campeanu, et al.
Journal of Palliative Medicine|August 24, 2018
The National Palliative Care Research Center: Ten Years of Promoting and Developing Research in Palliative CareR Sean Morrison, Melissa D Aldridge, James Block, et al.
Cancer Research Communications|January 30, 2023
DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1Allison V Mitchell, Jason Wu, Fanyan Meng, et al.
International Journal of Oncology|September 14, 2017
Cooperative oncogenic effect and cell signaling crosstalk of co‑occurring HER2 and mutant PIK3CA in mammary epithelial cellsLun Dong, Fanyan Meng, Ling Wu, et al.
Oncogene|October 5, 2021
RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNAC James Block, Allison V Mitchell, Ling Wu, et al.
Scientific Reports|January 20, 2019
Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBCLing Wu, Fanyan Meng, Lun Dong, et al.
Nature Communications|November 8, 2019
EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogrammingFanyan Meng, Ling Wu, Lun Dong, et al.
Nature Communications|November 2, 2022
FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasisAllison V Mitchell, Ling Wu, C James Block, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Aging|November 20, 2015
Reversing cancer stemnessJames Block, Fanyan Meng, Guojun Wu
Scientific Reports|November 30, 2019
A stroma-corrected ZEB1 transcriptional signature is inversely associated with antitumor immune activity in breast cancerC James Block, Gregory Dyson, Ion John Campeanu, et al.
Journal of Palliative Medicine|August 24, 2018
The National Palliative Care Research Center: Ten Years of Promoting and Developing Research in Palliative CareR Sean Morrison, Melissa D Aldridge, James Block, et al.
Cancer Research Communications|January 30, 2023
DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1Allison V Mitchell, Jason Wu, Fanyan Meng, et al.
International Journal of Oncology|September 14, 2017
Cooperative oncogenic effect and cell signaling crosstalk of co‑occurring HER2 and mutant PIK3CA in mammary epithelial cellsLun Dong, Fanyan Meng, Ling Wu, et al.
Oncogene|October 5, 2021
RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNAC James Block, Allison V Mitchell, Ling Wu, et al.
Scientific Reports|January 20, 2019
Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBCLing Wu, Fanyan Meng, Lun Dong, et al.
Nature Communications|November 8, 2019
EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogrammingFanyan Meng, Ling Wu, Lun Dong, et al.
Nature Communications|November 2, 2022
FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasisAllison V Mitchell, Ling Wu, C James Block, et al.
Pageof 1